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Worldwide, tuberculosis (TB) remains the most frequent and important infectious disease causing
morbidity and death. One-third of the world’s population is infected with Mycobacterium tubercu-
losis (M. tb), the etiological agent of TB. The World Health Organization estimates that about 8–10
million new TB cases occur annually worldwide, and the incidence of TB is currently increasing. In
this context, TB is in the top three (with malaria and HIV), being the leading cause of death from
a single-infectious agent, and approximately three million deaths are attributable to TB annually. In
particular, pulmonary TB, the most common form of TB, is a highly contagious and life-threatening
disease. A major underlying factor responsible for increased susceptibility to M. tb is co-infection
with HIV and the subsequent acquired immune deficiency syndrome. As of 2010, an estimated 34
million people are living with HIV infection worldwide, with an additional 2.7 million people newly
infected each year. Of those 34 million living with HIV, 22.9 million live in sub-Saharan Africa,
a region where M. tb is endemic. One of the hallmarks of AIDS brought on by HIV infection is
increased susceptibility to opportunistic infections, includingM. tb. Individuals with type II diabetes
and cigarette smokers are also increasingly susceptible toM. tb infection. Successful control ofM. tb
infection requires effective innate and adaptive immune responses inside the granuloma leading to
either killing or inhibition in the growth of M. tb. This Research Topic is a compilation of original
research findings and review articles that are mainly centered on the pathogenesis of TB and host
immune responses againstM. tb infection. The articles in this Research Topic include
(a) Experimental findings describing how different subsets of primary human dendritic cells
respond toM. tb infection (1).
(b) A comprehensive review on the variety of mechanisms by which mycobacteria subverts the
host immune responses and intracellular effector mechanisms, leading to successful survival of
the pathogen (2).
(c) Research article demonstrating that the mycobacterial gene, Rv1169c modifies the fatty acids
in the cell wall of the pathogen, and induces necrosis in the host cells, thereby functioning as a
virulence factor (3).
(d) A hypothetical and theory-based article describing the particle size distribution of cough
aerosols as an important predictor of primary upper airway disease and cervical lymphadenitis
in exposed hosts. The authors of this study hypothesize that large droplet aerosols (>5μm)
containingM. tbwill be deposited in the upper airway and this in turn can induce host immune
responses without establishing infection (4).
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(e) Research findings that illustrate that IL-17 inhibits apop-
tosis of M. bovis BCG- or M. tb-infected macrophages
thus hampering the ability of host cells to control bacterial
growth (5).
(f) Review article describing the direct and indirectmechanisms
by which natural killer cells controlM. tb infection, and the
effects of glutathione in improving the functions of natural
killer cells to controlM. tb infection (6).
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